Document is current
Any future updates will be listed below
-
Authors
Pena, Maria João
Pinto, Alex
de Almeida, Manuela Ferreira
de Sousa Barbosa, Catarina
Ramos, Paula Cristina
Rocha, Sara
Guimas, Arlindo
Ribeiro, Rosa
Martins, Esmeralda
Bandeira, Anabela
Dias, Cláudia Camila
MacDonald, Anita
Borges, Nuno
Rocha, Júlio César http://orcid.org/0000-0002-4977-8345
- License Information
-
More Information
Article History
Received: 5 November 2020
Accepted: 2 February 2021
First Online: 13 February 2021
Ethics approval and consent to participate
: This study was approved by the Ethics Committee of Centro de Genética Médica, Centro Hospitalar Universitário do Porto, on 18th May 2015, under the umbrella of the project TNSPKU (Trends in Nutritional Status of Patients with Phenylketonuria), with the reference 2015.101 (092-DEFI/087-CES). Written informed consent was obtained from each patient or caregiver (age dependent) during the routine nutritional appointment.
: Not applicable.
: A.P. has received an educational grant from Cambrooke Therapeutics and grants from Vitaflo, Nutricia, Merck Serono, BioMarin, and Mevalia to attend scientific meetings. M.F.A. received grants from Glutamine, Nutricia, Merck Serono, BioMarin, Orphan, and Lifediet to attend congress and for education. A.M. has received research funding and honoraria from Nutricia, Vitaflo International, BioMarin, Mevalia, and Pharma Galen. She is a member of the European Nutrition Expert Panel (BioMarin), and a member of the following advisory boards: the European PKU Group Board (BioMarin), Element (Danone-Nutricia), Excemed, Arla, and Applied Pharma Research. J.C.R. is member of the European Nutrition Expert Panel (BioMarin) and of the advisory boards of Applied Pharma Research and Nutricia. He has received speaker’s fees from Applied Pharma Research, Merck Serono, BioMarin, Nutricia, Vitaflo, Cambrooke, PIAM, and Lifediet.
